Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;38(5):1024-1025.
doi: 10.1038/s41433-023-02808-1. Epub 2023 Nov 2.

Down syndrome and autoimmune eye disease

Joyce J Mathan  1 , Akilesh Gokul  1 , Rachael L Niederer  1 , Charles N J McGhee  2
Affiliations

Down syndrome and autoimmune eye disease

Joyce J Mathan et al. Eye (Lond). 2024 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Zaki AM, Pasadhika S, Huang JC, Thomas AS, Burkholder BM, Lim LL, et al. Characterization of autoimmune eye disease in association with Down’s syndrome. Eye. 2023. 10.1038/s41433-023-02706-6. - PMC - PubMed
    1. Mathan J. Keratoconus in Down syndrome: prevalence, assessment, visual disability, quality of life and corneal cross linking [dissertation]. University of Auckland; 2022:101–39.
    1. Acharya NR, Tham VM, Esterberg E, Borkar DS, Parker JV, Vinoya AC, et al. Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study. JAMA Ophthalmol. 2013;131:1405–12. doi: 10.1001/jamaophthalmol.2013.4237. - DOI - PubMed
    1. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33:197–207. doi: 10.1016/j.jaut.2009.09.008. - DOI - PMC - PubMed
    1. Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266. doi: 10.1016/j.coi.2022.102266. - DOI - PMC - PubMed